Articles & Resources

Market Trends

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Market Trends

Clear filter

Building A Robust Cell and Gene Therapy Supply Chain

Cell and gene therapy manufacturers need a supply chain that is both nimble and adaptable to sufficiently support therapeutic development

Diagnostic Device Development in the Era of Cybersecurity Regulations

The interconnectivity of diagnostic technology is revolutionizing healthcare - but also introducing significant risk. Here’s what you need to know about diagnostic device development in the era of cybersecurity regulations.

Checklist: How to Develop a Cell Therapy Manufacturing Roadmap

Developing a manufacturing roadmap early on is essential when scaling cell therapy manufacturing.

Why So Shy? Implementing Disruptive Technologies with Confidence in Cell Therapy

Panelists from Lonza, Takeda and Vor Biopharma share their insights on how to best introduce disruptive technologies into cell therapy manufacturing processes.

Users Expect Intuitive Product Experiences – 4 Considerations for POC Success

Point of Care (POC) users don’t want a lab instrument. Here are 4 considerations for designing intuitive diagnostic products optimized for POC.

4 Must-Haves for POC Diagnostic Solutions

What product features are required for success in Point of Care (POC) diagnostics? Two executives from leading POC companies share their 4 “must-haves”.

5 Things to Look Out for in Cell Therapy Supply Chain in 2022

How to navigate global supply chain challenges to help avoid cell therapy manufacturing production bottlenecks this year

How to Successfully Design and Commercialize a Point of Care Platform

In our recent webinar, Kfir Oved from MeMed and Paul Gargan from Prominex shared real-world experiences and insights for succeeding in the Point of Care (POC) diagnostics market.

Key Considerations for Automating Cell Therapy Manufacturing Processes

Invetech’s Jon Ellis and TreeFrog Therapeutics’ Maxime Feyeux discuss cell therapy process automation, development time and costs and automating ancillary processes.

Rethink Cell Therapy QC with Release by Exception

The cell and gene therapy industry could move away from lengthy and costly QC reviews - while still upholding high quality standards - by employing release by exception methods.

Reducing the Manufacturing Costs of Allogeneic Cell Therapies

For allogeneic cell therapies to reach their therapeutic potential, it comes down to achieving scalable and robust manufacturing processes.

3 Strategies for Delivering a Point of Care Platform That Stands Out

To attract investment and get traction in the market, Point of Care diagnostic developers must deliver a platform that is differentiated. Focus on these 3 essential strategies to make it happen.